PortfoliosLab logo

Adial Pharmaceuticals, Inc. (ADIL)

Equity · Currency in USD · Last updated Nov 30, 2022

Company Info

ISINUS00688A1060
CUSIP00688A106
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.26
Year Range$0.26 - $2.94
EMA (50)$0.36
EMA (200)$1.11
Average Volume$94.03K
Market Capitalization$6.96M

ADILShare Price Chart


Loading data...

ADILPerformance

The chart shows the growth of $10,000 invested in Adial Pharmaceuticals, Inc. in Jul 2018 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $640 for a total return of roughly -93.60%. All prices are adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%20.00%40.00%JulyAugustSeptemberOctoberNovember
-81.35%
-5.25%
ADIL (Adial Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ADILCompare to other instruments

Search for stocks, ETFs, and funds to compare with ADIL

ADILReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-16.45%1.45%
6M-79.61%-4.82%
YTD-90.41%-16.96%
1Y-90.91%-13.86%
5Y-46.95%8.14%
10Y-46.95%8.14%

ADILMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-22.96%-0.96%-2.43%-29.85%-10.64%6.35%-51.49%-16.92%-35.19%-14.29%-13.67%
202126.47%16.74%-3.59%-9.09%12.27%3.24%-4.31%68.03%4.63%-25.17%-13.40%-2.88%
2020-24.48%-20.88%-9.72%14.08%8.90%-13.94%15.83%-14.29%61.59%-21.97%33.91%-27.04%
20196.84%-34.00%-4.99%-23.62%-29.39%-9.19%7.14%-8.33%-8.48%2.65%-6.45%66.21%
2018-1.23%-22.90%-11.64%-30.48%102.70%33.33%

ADILSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Adial Pharmaceuticals, Inc. Sharpe ratio is -1.02. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.200.00JulyAugustSeptemberOctoberNovember
-1.02
-0.63
ADIL (Adial Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ADILDividend History


Adial Pharmaceuticals, Inc. doesn't pay dividends

ADILDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember
-96.89%
-17.49%
ADIL (Adial Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ADILWorst Drawdowns

The table below shows the maximum drawdowns of the Adial Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Adial Pharmaceuticals, Inc. is 96.89%, recorded on Nov 29, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.89%Jan 16, 2019976Nov 29, 2022
-71.53%Aug 2, 201874Nov 14, 201825Dec 21, 201899
-18.86%Dec 27, 20183Dec 31, 20181Jan 2, 20194
-11.11%Jan 4, 20192Jan 7, 20193Jan 10, 20195
-1.23%Jul 30, 20182Jul 31, 20181Aug 1, 20183

ADILVolatility Chart

Current Adial Pharmaceuticals, Inc. volatility is 49.01%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%JulyAugustSeptemberOctoberNovember
49.01%
13.39%
ADIL (Adial Pharmaceuticals, Inc.)
Benchmark (^GSPC)